Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Genetics01:28

Human Genetics

485
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
485
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

45
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
45
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

294
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
294
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

114
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
114
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

32
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
32
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

27
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
27

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast Cancer.

Cell death discovery·2026
Same author

Telerehabilitation in children and adolescents with intellectual disability: a systematic review.

Frontiers in psychiatry·2026
Same author

NMR metabolomics assessment of neural commitment of human dental pulp-derived stem cells.

Frontiers in molecular biosciences·2026
Same author

Costs of autism spectrum disorders and access to services in Spain.

BMC health services research·2026
Same author

Mapping, displaying, and facilitating access to autism services: an Italian eHealth solution.

International journal of medical informatics·2026
Same author

Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency.

Science advances·2026

Related Experiment Video

Updated: May 15, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

9.9K

Biogenic Amine Metabolism and Its Genetic Variations in Autism Spectrum Disorder: A Comprehensive Overview.

Claudio Tabolacci1, Angela Caruso1, Martina Micai1

  • 1Coordination and Promotion of Research, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Biomolecules
|April 30, 2025
PubMed
Summary

Biogenic amines play a crucial role in autism spectrum disorder (ASD) pathogenesis. Genetic links to amine metabolism enzymes highlight their potential as biomarkers for early ASD screening and personalized interventions.

Keywords:
autism spectrum disorderbiogenic aminesmetabolismneurodevelopmental disorders

More Related Videos

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

1.4K
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

13.9K

Related Experiment Videos

Last Updated: May 15, 2025

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

9.9K
Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

1.4K
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

13.9K

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with increasing global prevalence.
  • Pathogenic mechanisms underlying ASD remain poorly understood, hindering early diagnosis and targeted treatments.
  • Biogenic amines (e.g., serotonin, dopamine) are vital neurotransmitters and neuromodulators implicated in brain function.

Purpose of the Study:

  • To review the role of biogenic amines in ASD.
  • To explore genetic alterations in enzymes involved in biogenic amine metabolism in ASD.
  • To highlight the potential of biogenic amines as biomarkers for ASD.

Main Methods:

  • Literature review focusing on genetic associations and biochemical pathways.
  • Analysis of studies linking gene variations in biogenic amine metabolism to ASD.
  • Synthesis of current knowledge on biogenic amine function in the central nervous system relevant to ASD.

Main Results:

  • Genetic variations in enzymes responsible for biogenic amine synthesis and degradation are frequently observed in ASD populations.
  • Biogenic amines exhibit pleiotropic activities in the CNS, influencing neurotransmission and neuromodulation relevant to ASD.
  • Alterations in biogenic amine levels and metabolism are increasingly recognized as potential contributors to ASD pathophysiology.

Conclusions:

  • Biogenic amines represent a promising area for ASD biomarker discovery, aiding early screening and subtype classification.
  • Understanding genetic links to biogenic amine metabolism can provide insights into ASD physiopathology.
  • Targeting biogenic amine pathways may offer novel therapeutic strategies or inform personalized interventions for ASD.